Koyfin Home > Directory > Health Care > Inovio Pharma > Return on Equity %

Inovio Pharma Return on Equity % Chart (INO)

Inovio Pharma annual/quarterly Return on Equity % from 2010 to 2020.
  • Inovio Pharma Return on Equity % for the quarter ending June 06, 2020 was -276.15 a 26.36% decrease of -72.80 year over year
  • Inovio Pharma Return on Equity % for the last 12 months ending June 06, 2020 was -184.48 a 10.55% decrease of -19.47 year over year
  • Inovio Pharma Annual Return on Equity % for 2019 was -260.83 a 67.60% decrease of -176.33 from 2018
  • Inovio Pharma Annual Return on Equity % for 2018 was -84.50 a 21.47% decrease of -18.14 from 2017
  • Inovio Pharma Annual Return on Equity % for 2017 was -66.35 a 25.74% decrease of -17.08 from 2016
Other Margins & Efficiency Metrics:
  • Inovio Pharma EBITDA Margin for the quarter ending June 06, 2018 was $-16m a -1,153.83% increase of 186m year over year
  • Inovio Pharma Return on Capital % for the quarter ending December 12, 2018 was -77.33 a 17.16% decrease of -13.27 year over year
View Chart On Koyfin

Quarterly INO Return on Equity % Data

06/2020-276.15
03/2020-137.16
12/2019-734.95
09/2019-203.35
06/2019-172.17
03/2019-139.47
12/2018-138.25
09/2018-92.99
06/2018-23.65
03/2018-101.26

Annual INO Return on Equity % Data

2019-260.83
2018-84.50
2017-66.35
2016-49.27
2015-20.25
2014-43.96
2013-150.60
2012-47.66
2011-32.23
2010-32.58